A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants

NCT05848440 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG: AZD9550
DRUG: AZD9550
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]